Skip to main content
. 2022 Jun 10;7(3):100507. doi: 10.1016/j.esmoop.2022.100507

Figure 1.

Figure 1

Flowchart of patient disposition.

AACR, American Association for Cancer Research; ASCO, American Society of Clinical Oncology; ELCC, European Lung Cancer Congress; ESMO, European Society of Medical Oncology; WCLC, World Conference on Lung Cancer.

aReasons for exclusion: 38 review/meta-analysis, 36 non-randomized trials, 8 no epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) treatment, 7 no survival results, 7 no results by smoking, 4 subgroup analysis, 4 study design paper, 3 no angiogenesis inhibitor treatment, 2 clinical practice guidelines, 2 reply letter, 2 no comparison with EGFR TKI, 2 pooled analysis, 2 updated results, 1 case study, 1 highlights, 1 study on mice.